B. Farrer

发表

Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes Mellitus.

Nadine H. Elowe, Brian T. Campbell, J. Berger, 2017, Bioorganic & medicinal chemistry letters.

Comparison of the binding of cadmium(II), mercury(II), and arsenic(III) to the de novo designed peptides TRI L12C and TRI L16C.

L. Hemmingsen, V. Pecoraro, T. Weng, 2002, Journal of the American Chemical Society.

A randomized, double-blind, Phase 1 study of IN-006, an inhaled antibody treatment for COVID-19

T. Moench, M. McSweeney, J. Hutchins, 2022, medRxiv.

Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.

Nadine H. Elowe, Brian T. Campbell, J. Berger, 2017, Bioorganic & medicinal chemistry letters.

Redox pathways in DNA oxidation: kinetic studies of guanine and sugar oxidation by para-substituted derivatives of oxoruthenium(IV).

H. Thorp, B. Farrer, 2000, Inorganic chemistry.

Thermodynamic model for the stabilization of trigonal thiolato mercury(II) in designed three-stranded coiled coils.

V. Pecoraro, B. Farrer, N. Harris, 2001, Biochemistry.

Risk assessment and physicochemical characterization of a metastable dihydrate API phase for intravenous formulation development.

Narayan Variankaval, Li Li, Li Li, 2010, Journal of pharmaceutical sciences.

Hg(II) binding to a weakly associated coiled coil nucleates an encoded metalloprotein fold: A kinetic analysis

V. Pecoraro, B. Farrer, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Arsenic(III)-cysteine interactions stabilize three-helix bundles in aqueous solution.

V. Pecoraro, J. Penner‐Hahn, B. Farrer, 2000, Inorganic chemistry.

Driving Force and Isotope Dependence of the Kinetics of Proton-Coupled Electron Transfer in Oxoruthenium(IV) Polypyridyl Complexes

H. Thorp, B. T. Farrer, B. Farrer, 1999 .

Heavy-metal complexation by de novo peptide design.

V. Pecoraro, B. Farrer, 2002, Current opinion in drug discovery & development.